In a Spanish population of 359 lung cancer patients and 375 healthy controls, Marin et al. found that the frequency of XPC PAT+ allele was 45.0% in cases and 39.5% in controls, the difference being statistically significant (P = 0.032) [38]. The gene discussed is XPC; the disease is lung cancer.